Cargando...
The Place of PET to Assess New Therapeutic Effectiveness in Neurodegenerative Diseases
In vivo exploration of neurodegenerative diseases by positron emission tomography (PET) imaging has matured over the last 20 years, using dedicated radiopharmaceuticals targeting cellular metabolism, neurotransmission, neuroinflammation, or abnormal protein aggregates (beta-amyloid and intracellular...
Gardado en:
| Publicado en: | Contrast Media Mol Imaging |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Hindawi
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5985069/ https://ncbi.nlm.nih.gov/pubmed/29887768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/7043578 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|